Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review

OBJECTIVES: Although many studies have reported on the cost-effectiveness of bosentan for treating pulmonary arterial hypertension (PAH), a systematic review of economic evaluations of bosentan is currently lacking. Objective evaluation of current pharmacoeconomic evidence can assist decision makers...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Can Respir J
Hlavní autoři: You, Ruxu, Qian, Xinyu, Tang, Weijing, Xie, Tian, Zeng, Fang, Chen, Jun, Zhang, Yu, Liu, Jinyu
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2018
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276424/
https://ncbi.nlm.nih.gov/pubmed/30581511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1015239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky